Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Verena Hafner

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Therapeutische Umschau. Revue Therapeutique|December 25, 2010
[Herbal drug-drug interaction and adverse drug reactions]Verena Hafner-Blumenstiel
Psychophysiology|November 19, 2011
Aiming for the bull's eye: Preparing for throwing investigated with event-related brain potentialsRomy Frömer, Verena Hafner, Werner Sommer
Antimicrobial Agents and Chemotherapy|September 17, 2008
Inhibition of voriconazole metabolism by chloramphenicol in an adolescent with central nervous system aspergillosisVerena Hafner, Nadine Albermann, Walter E Haefeli, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 8, 2006
Topoisomerase II beta expression level correlates with doxorubicin-induced apoptosis in peripheral blood cellsGisela Kersting, Mladen V Tzvetkov, Klaus Huse, et al.
European Journal of Clinical Pharmacology|September 13, 2012
Effect of the CYP3A inhibitor ketoconazole on the PXR-mediated induction of CYP3A activityInes Fuchs, Verena Hafner-Blumenstiel, Christoph Markert, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 5, 2008
Calcium load during administration of calcium carbonate or sevelamer in individuals with normal renal functionTilman Heinrich, Hartmut Heidt, Verena Hafner, et al.
Antimicrobial Agents and Chemotherapy|April 7, 2010
Pharmacokinetics of sulfobutylether-beta-cyclodextrin and voriconazole in patients with end-stage renal failure during treatment with two hemodialysis systems and hemodiafiltrationVerena Hafner, David Czock, Jürgen Burhenne, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Therapeutische Umschau. Revue Therapeutique|December 25, 2010
[Herbal drug-drug interaction and adverse drug reactions]Verena Hafner-Blumenstiel
Psychophysiology|November 19, 2011
Aiming for the bull's eye: Preparing for throwing investigated with event-related brain potentialsRomy Frömer, Verena Hafner, Werner Sommer
Antimicrobial Agents and Chemotherapy|September 17, 2008
Inhibition of voriconazole metabolism by chloramphenicol in an adolescent with central nervous system aspergillosisVerena Hafner, Nadine Albermann, Walter E Haefeli, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 8, 2006
Topoisomerase II beta expression level correlates with doxorubicin-induced apoptosis in peripheral blood cellsGisela Kersting, Mladen V Tzvetkov, Klaus Huse, et al.
European Journal of Clinical Pharmacology|September 13, 2012
Effect of the CYP3A inhibitor ketoconazole on the PXR-mediated induction of CYP3A activityInes Fuchs, Verena Hafner-Blumenstiel, Christoph Markert, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 5, 2008
Calcium load during administration of calcium carbonate or sevelamer in individuals with normal renal functionTilman Heinrich, Hartmut Heidt, Verena Hafner, et al.
Antimicrobial Agents and Chemotherapy|April 7, 2010
Pharmacokinetics of sulfobutylether-beta-cyclodextrin and voriconazole in patients with end-stage renal failure during treatment with two hemodialysis systems and hemodiafiltrationVerena Hafner, David Czock, Jürgen Burhenne, et al.
Pageof 1